Literature DB >> 15967275

Identification of the pharmaceuticals for human use contaminating the Italian aquatic environment.

Ettore Zuccato1, Sara Castiglioni, Roberto Fanelli.   

Abstract

A predictive approach seems useful to identify pharmaceuticals in the environment and give an idea of overall levels of contamination, so as to restrict monitoring to those molecules most likely to be contaminants. We propose an approach based on two parts. The first is to rank the molecules according to the predicted environmental loads; the second is to refine the list by analysing the pharmaceuticals in sewage treatment plants (STPs) and comparing the concentrations with levels previously measured in surface water. This approach identified a restricted group of priority pollutants (ofloxacin, furosemide, atenolol, hydrochlorothiazide, carbamazepine, ibuprofen, spiramycin, bezafibrate, erythromycin, lincomycin and clarithromycin) in the aquatic environment in Italy, for further studies and monitoring.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15967275     DOI: 10.1016/j.jhazmat.2005.03.001

Source DB:  PubMed          Journal:  J Hazard Mater        ISSN: 0304-3894            Impact factor:   10.588


  33 in total

1.  Concentrations of dissolved herbicides and pharmaceuticals in a small river in Luxembourg.

Authors:  Berenike Meyer; Jean-Yannick Pailler; Cédric Guignard; Lucien Hoffmann; Andreas Krein
Journal:  Environ Monit Assess       Date:  2010-11-27       Impact factor: 2.513

2.  Antineoplastic compounds in the environment-substances of special concern.

Authors:  Klaus Kümmerer; Annette Haiß; Armin Schuster; Arne Hein; Ina Ebert
Journal:  Environ Sci Pollut Res Int       Date:  2014-12-06       Impact factor: 4.223

Review 3.  A perspective on the potential risks of emerging contaminants to human and environmental health.

Authors:  Lílian Cristina Pereira; Alecsandra Oliveira de Souza; Mariana Furio Franco Bernardes; Murilo Pazin; Maria Júlia Tasso; Paulo Henrique Pereira; Daniel Junqueira Dorta
Journal:  Environ Sci Pollut Res Int       Date:  2015-07-24       Impact factor: 4.223

4.  Introduction of human pharmaceuticals from wastewater treatment plants into the aquatic environment: a rural perspective.

Authors:  Carolina Nebot; Raquel Falcon; Kenneth G Boyd; Stuart W Gibb
Journal:  Environ Sci Pollut Res Int       Date:  2015-03-05       Impact factor: 4.223

5.  An online SPE LC-MS/MS method for the analysis of antibiotics in environmental water.

Authors:  Meierjohann Axel; Kortesmäki Ewelina; Brozinski Jenny-Maria; Kronberg Leif
Journal:  Environ Sci Pollut Res Int       Date:  2017-02-16       Impact factor: 4.223

6.  Fate of selected pharmaceuticals in river waters.

Authors:  P Calza; C Medana; E Padovano; V Giancotti; C Minero
Journal:  Environ Sci Pollut Res Int       Date:  2012-08-01       Impact factor: 4.223

7.  Human metabolites and transformation products of cyclophosphamide and ifosfamide: analysis, occurrence and formation during abiotic treatments.

Authors:  Marjeta Česen; Tina Kosjek; Francesco Busetti; Boris Kompare; Ester Heath
Journal:  Environ Sci Pollut Res Int       Date:  2016-02-27       Impact factor: 4.223

8.  Systematic screening of common wastewater-marking pharmaceuticals in urban aquatic environments: implications for environmental risk control.

Authors:  Haidong Zhou; Qingjun Zhang; Xuelian Wang; Qianqian Zhang; Lixin Ma; Yong Zhan
Journal:  Environ Sci Pollut Res Int       Date:  2014-02-21       Impact factor: 4.223

9.  Quantifying interactions between propranolol and dissolved organic matter (DOM) from different sources using fluorescence spectroscopy.

Authors:  Na Peng; Kaifeng Wang; Guoguang Liu; Fuhua Li; Kun Yao; Wenying Lv
Journal:  Environ Sci Pollut Res Int       Date:  2014-01-05       Impact factor: 4.223

10.  Fast photocatalytic degradation of pharmaceutical micropollutants and ecotoxicological effects.

Authors:  Isabella Natali Sora; Davide Fumagalli
Journal:  Environ Sci Pollut Res Int       Date:  2016-09-17       Impact factor: 4.223

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.